Groowe Groowe / Newsroom / IGC
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IGC News

IGC Pharma, Inc.

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts

accessnewswire.com
IGC

IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease

accessnewswire.com
IGC

Form 8-K

sec.gov
IGC

IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness

accessnewswire.com
IGC

New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)

accessnewswire.com
ACXP DVLT IGC NRXP SNYR TRN VTIX VVOS YYGH MDCX ATON

New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning

accessnewswire.com
IGC

IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025

accessnewswire.com
IGC

IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026

accessnewswire.com
IGC

Flagship Pioneering Appoints Eric Topol as Academic Advisor to Advance Preemptive Health and Medicine Initiative

prnewswire.com
FHTX IGC SANA

Form 8-K

sec.gov
IGC